| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1010232917 |
| P356 | DOI | 10.1038/SJ.BJC.6600625 |
| P932 | PMC publication ID | 2376194 |
| P698 | PubMed publication ID | 12402142 |
| P5875 | ResearchGate publication ID | 11062022 |
| P50 | author | Nicola J. Brown | Q39411533 |
| P2093 | author name string | S P Balasubramanian | |
| M W R Reed | |||
| P2860 | cites work | The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer | Q77359402 |
| Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection | Q77374170 | ||
| Association between functional polymorphism in EGF gene and malignant melanoma | Q77639039 | ||
| A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription | Q77670013 | ||
| Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer | Q77827950 | ||
| Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene | Q78068271 | ||
| Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer | Q78197100 | ||
| Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region | Q78257257 | ||
| Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 | Q22254704 | ||
| Searching for genetic determinants in the new millennium | Q22337300 | ||
| Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
| Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production | Q24676008 | ||
| Fibroblast growth factors, their receptors and signaling | Q28140520 | ||
| Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22 | Q28253848 | ||
| Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers | Q28609620 | ||
| Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains | Q28609650 | ||
| Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. | Q32046361 | ||
| The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients | Q33179735 | ||
| VEGFs, receptors and angiogenesis | Q33644265 | ||
| Matrix metalloproteinases in tumour invasion and metastasis | Q33765792 | ||
| A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility | Q33955812 | ||
| Choosing a retrospective design to assess joint genetic and environmental contributions to risk | Q33995958 | ||
| A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma | Q34095548 | ||
| Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases | Q34096205 | ||
| Angiostatin and endostatin: endogenous inhibitors of tumor growth | Q34146320 | ||
| Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs | Q34178829 | ||
| Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy | Q34354300 | ||
| Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology | Q34435505 | ||
| Candidate gene case-control association studies: advantages and potential pitfalls | Q34459045 | ||
| Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies | Q34498272 | ||
| Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications | Q34569994 | ||
| Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3). | Q35075746 | ||
| Polymorphism in the interferon-alpha gene family | Q35882376 | ||
| Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor | Q35961109 | ||
| Urokinase and macrophages in tumour angiogenesis | Q36081712 | ||
| Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients | Q73117315 | ||
| Detection of polymorphisms in the human urokinase-type plasminogen activator gene | Q73145753 | ||
| MMP1 and MMP3 polymorphisms in promoter regions and cancer | Q73269653 | ||
| Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis | Q73316711 | ||
| Molecular genetic analysis of TGF-beta1 in ovarian neoplasia | Q73334932 | ||
| Molecular genetic analysis of TGF beta1 in breast cancer | Q73334935 | ||
| Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma | Q73592380 | ||
| Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma | Q73623100 | ||
| IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma | Q73732686 | ||
| The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers | Q73734124 | ||
| Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese | Q73907419 | ||
| TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study | Q73919147 | ||
| Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production | Q74126993 | ||
| Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis | Q74191318 | ||
| Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer | Q74231941 | ||
| Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration | Q74251186 | ||
| Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech population | Q74258998 | ||
| Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer | Q74310813 | ||
| Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer | Q74442162 | ||
| Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
| Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis | Q36569348 | ||
| Activating mutations for the met tyrosine kinase receptor in human cancer | Q36595980 | ||
| Polymorphisms of the human IFNG gene noncoding regions | Q38315683 | ||
| Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells | Q38472948 | ||
| A novel germ line juxtamembrane Met mutation in human gastric cancer | Q40847293 | ||
| Metalloproteases and urokinase in angiogenesis and tumor progression. | Q40860422 | ||
| The tumor necrosis factor ligand and receptor families. | Q40990575 | ||
| The role of fibroblasts in tumor behavior | Q41121042 | ||
| Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. | Q41196594 | ||
| Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. | Q41481649 | ||
| Proteolysis in human breast and colorectal cancer | Q42095382 | ||
| Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. | Q43540221 | ||
| Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma | Q43558001 | ||
| Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. | Q43590585 | ||
| Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. | Q43698933 | ||
| Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production | Q43824472 | ||
| Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele | Q43878478 | ||
| Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer | Q44212210 | ||
| Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese | Q47727081 | ||
| The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). | Q47767769 | ||
| Analysis of TNFB and TNFA NcoI RFLP in colorectal cancer | Q47932706 | ||
| Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions | Q47978883 | ||
| In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. | Q47982553 | ||
| An investigation of polymorphism in the interleukin-10 gene promoter | Q48054541 | ||
| Novel IFN-alpha receptor promoter polymorphisms | Q48356788 | ||
| A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels | Q48386340 | ||
| Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. | Q53383014 | ||
| Polymorphisms of tumour necrosis factors A and B in breast cancer. | Q53674100 | ||
| Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. | Q54185666 | ||
| A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. | Q55409923 | ||
| Fibroblast growth factors are required for efficient tumor angiogenesis | Q56787224 | ||
| Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1 | Q57279239 | ||
| Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis | Q57279243 | ||
| Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease | Q57607780 | ||
| Influence of cytokine gene polymorphisms on the development of prostate cancer | Q57694657 | ||
| Haplotype tagging for the identification of common disease genes | Q59200321 | ||
| Influence of TNFα gene polymorphisms on TNFα production and disease | Q61971724 | ||
| Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma | Q62644558 | ||
| Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity | Q68290719 | ||
| A highly polymorphic CA/GT repeat in intron 3 of the human urokinase receptor gene (PLAUR) | Q70888860 | ||
| Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy | Q70974562 | ||
| Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10 | Q71029697 | ||
| Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue | Q72132774 | ||
| 10.5-kb homozygote of tumor necrosis factor-beta gene is associated with a better prognosis in gastric cancer patients | Q72628431 | ||
| The study of tumor necrosis factor beta gene polymorphism in lung cancer patients | Q72785481 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic variation | Q349856 |
| angiogenesis | Q539568 | ||
| neoplasm | Q1216998 | ||
| neovascularization | Q1281049 | ||
| cancer | Q12078 | ||
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 1057-1065 | |
| P577 | publication date | 2002-11-01 | |
| 2002-11-04 | |||
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Role of genetic polymorphisms in tumour angiogenesis | |
| P478 | volume | 87 |
| Q54401128 | Association of Vascular Endothelial Growth Factor -2578C/A Gene Polymorphism in Chinese Patients with Colon Cancer |
| Q51567138 | Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction. |
| Q49568375 | Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma |
| Q37121685 | Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. |
| Q24644901 | Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma |
| Q54197944 | Estimation of vascular endothelial growth factor gene -460 C/T polymorphism as a biomarker in oral squamous cell carcinoma patients from the Indian subcontinent. |
| Q36614414 | FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients |
| Q64057950 | Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas |
| Q36647381 | Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway |
| Q36172256 | Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies |
| Q53644294 | Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. |
| Q35045809 | HIF-1α -1790G>A polymorphism significantly increases the risk of digestive tract cancer: a meta-analysis |
| Q57707731 | Impact of serum biomarkers on esophageal squamous cell carcinoma |
| Q34418858 | Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes |
| Q24798836 | Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling |
| Q36982859 | Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab |
| Q33747831 | Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium |
| Q47150792 | Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab |
| Q24806157 | Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity |
| Q79256072 | Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma |
| Q37288368 | The GSTM1 null genotype increased risk of gastric cancer: a meta-analysis based on 46 studies |
| Q54544986 | Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. |
| Q37702734 | Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies |
| Q37343653 | Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis |
| Q42734729 | Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia |
| Q46714484 | WITHDRAWN: Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma |
Search more.